CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins

Stock Information for Avenir Wellness Solutions Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avenir Wellness Solutions Inc

Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.
CURE Pharmaceutical Letter to Shareholders
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference
Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV
Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins
CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.